Comparative analyses demonstrate that halogenated ligands modulate redox potentials in transition metal complexes, suggesting new design strategies.
Halogenation of ligands intensely modulates the redox and photophysical properties of transition-metal complexes, yet fully halogenated systems remain largely unexplored. Here we report the synthesis and structural characterization of homoleptic Ni(0) complexes with perhalogenated aryl isocyanide ligands [Ni(CN-C₆X₅)₄] (X = F, Cl). Comparative electrochemical studies reveal a dramatic anodic shift of the Ni(0)/Ni(I) couple from -0.60 V in [Ni(CN-C₆H₅)₄] to +0.03 V vs Fc+/0 for the perfluorinated species, reflecting the exceptional π-acceptor strength resulting from the C-H/C-F persubstitution. Surprisingly, metal-to-ligand charge-transfer (MLCT) absorption energies remain largely unchanged, a result supported by DFT calculations showing concurrent stabilization of both the Ni-centered HOMO and ligand-based LUMO. In contrast, the perchlorinated complex exhibits a red-shifted MLCT band due to asymmetric frontier-orbital tuning. Ultrafast transient absorption spectroscopy demonstrates ³MLCT excited states with lifetimes in the regime of 66-141 ps for all complexes. These findings establish perhalogenated isocyanides as powerful ligands for controlling excited-state redox potentials without altering excitation energies, an attractive feature for the rational design of robust Ni-based photoredox catalysts. More broadly, our findings establish ligand perhalogenation as a design strategy for developing new photoactive first-row transition metal complexes with potential applications in luminescent devices, photocatalysis, and photodynamic therapy.
No takes yet. Share an insight, caveat, or question.
Streit et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: